369x Filetype PPTX File size 1.00 MB Source: nwpgmd.nhs.uk
Aims
• Discuss parenteral nutrition (PN) in intestinal
failure related to advanced abdominal cancer
• Christie referral pathway for HPN
• Review some of the practicalities involved for
patients receiving HPN
• Not covering PN in cancer cachexia
Background
• Home Parenteral Nutrition (HPN) in advanced malignancy is
becoming increasingly common
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Total n= n= n= n= n= n= n= n= n= n= n=
112 101 138 157 148 228 262 351 472 400 420
Malignancy 13 17 16 24 14 32 43 66 116 102 115
New adult HPN registrations, 2005 and 2015
• Lack of consensus throughout the world, with the
proportion of HPN patients with cancer as the indication up
to 60% in some parts of Europe (Naghibi et al, 2014)
BANS report on Adult Home Parenteral Nutrition & Home Intravenous Fluids, 2016
IFU SRFT - referrals
Year Total referrals to IFU Total referrals for remote D
2009 – 10 147
2010 – 11 121
2011 – 12 126
2012 – 13 152 13
2013 – 14 156 7
2014 - 15 146 16
15 - 16 171 15
16 - 17 180 32
17 - 18 195 43
18 - 19 198 57
Primary malignancy
Gastro-intestinal n=16
Gynaecology n=29
other n=13
pseudomyxoma n=5
Others:
- Lymphoma - Carcinoid
- Mesothelioma - Urology
- Pancreatic
Background
• Failure to maintain weight and nutrition is
common in patients with cancer
• In those with a functioning and accessible GI
tract, use oral/enteral route of nutrition
• In those with intestinal failure secondary to
advanced abdominal malignancy (e.g.
inoperable malignant bowel obstruction)
consider parenteral nutrition
no reviews yet
Please Login to review.